{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:24:10Z","timestamp":1791397450299,"version":"4.3.3"},"reference-count":46,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2024,12,29]],"date-time":"2024-12-29T00:00:00Z","timestamp":1735430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["24-15-00185"],"award-info":[{"award-number":["24-15-00185"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The use of the concept of privileged structures significantly accelerates the search for new leads and their optimization. 6-(methylsulfonyl)-8-(4-methyl-4H-1,2,4-triazol-3-yl)-2-(5-nitro-2-furoyl)-2,6-diazaspiro[3.4]octane 1 has been identified as a lead, with MICs of 0.0124\u20130.0441 \u03bcg\/mL against MTb multiresistant strains. Several series of structural analogues have been synthesized, including variations in the periphery and simplifications of their scaffolds. All synthesized compounds were tested against the MTb H37Rv strain and ESKAPE panel of pathogens using serial broth dilutions. However, an attempt to optimize structure of 1 did not lead to the development of more active compounds which can work against MTb, but to substances with high activity against S. aureus. Induced-fit docking and MM-GBSA calculations determined a change in the likely biotarget from deazaflavin-dependent nitroreductase to azoreductases. The privileged nature of the scaffold was demonstrated by the detection of a different type of activity.<\/jats:p>","DOI":"10.3390\/ijms26010207","type":"journal-article","created":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T07:51:57Z","timestamp":1735631517000},"page":"207","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["You Win Some, You Lose Some: Modifying the Molecular Periphery of Nitrofuran-Tagged Diazaspirooctane Reshapes Its Antibacterial Activity Profile"],"prefix":"10.3390","volume":"26","author":[{"given":"Lyubov","family":"Vinogradova","sequence":"first","affiliation":[{"name":"Lomonosov Institute of Fine Chemical Technologies, MIREA\u2014Russian Technological University, Moscow 119454, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Komarova","sequence":"additional","affiliation":[{"name":"Lomonosov Institute of Fine Chemical Technologies, MIREA\u2014Russian Technological University, Moscow 119454, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6162-4851","authenticated-orcid":false,"given":"Alexey","family":"Lukin","sequence":"additional","affiliation":[{"name":"Lomonosov Institute of Fine Chemical Technologies, MIREA\u2014Russian Technological University, Moscow 119454, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxim","family":"Zhuravlev","sequence":"additional","affiliation":[{"name":"Lomonosov Institute of Fine Chemical Technologies, MIREA\u2014Russian Technological University, Moscow 119454, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry","family":"Deniskin","sequence":"additional","affiliation":[{"name":"Lomonosov Institute of Fine Chemical Technologies, MIREA\u2014Russian Technological University, Moscow 119454, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Poliakova","sequence":"additional","affiliation":[{"name":"Lomonosov Institute of Fine Chemical Technologies, MIREA\u2014Russian Technological University, Moscow 119454, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9735-9690","authenticated-orcid":false,"given":"Mikhail","family":"Chudinov","sequence":"additional","affiliation":[{"name":"Lomonosov Institute of Fine Chemical Technologies, MIREA\u2014Russian Technological University, Moscow 119454, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0385-922X","authenticated-orcid":false,"given":"Maxim","family":"Gureev","sequence":"additional","affiliation":[{"name":"Institute of Cytology, Russian Academy of Sciences, Saint Petersburg 194064, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9161-466X","authenticated-orcid":false,"given":"Marine","family":"Dogonadze","sequence":"additional","affiliation":[{"name":"Saint-Petersburg State Research Institute of Phthisiopulmonology of the Ministry of Healthcare of the Russian Federation, Saint Petersburg 191036, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Vinogradova","sequence":"additional","affiliation":[{"name":"Saint-Petersburg State Research Institute of Phthisiopulmonology of the Ministry of Healthcare of the Russian Federation, Saint Petersburg 191036, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizaveta","family":"Rogacheva","sequence":"additional","affiliation":[{"name":"Pasteur Institute of Epidemiology and Microbiology, Saint Petersburg 197101, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9115-3250","authenticated-orcid":false,"given":"Lyudmila","family":"Kraeva","sequence":"additional","affiliation":[{"name":"Pasteur Institute of Epidemiology and Microbiology, Saint Petersburg 197101, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5450-3135","authenticated-orcid":false,"given":"Yuri","family":"Porozov","sequence":"additional","affiliation":[{"name":"Laboratory of Angiopathology, The Institute of General Pathology and Pathophysiology, Moscow 125315, Russia"},{"name":"Advitam Laboratory, 11108 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3509-3978","authenticated-orcid":false,"given":"Viktor","family":"Korzhikov-Vlakh","sequence":"additional","affiliation":[{"name":"Department of Medical Chemistry, Institute of Chemistry, Saint Petersburg State University, Saint Petersburg 199034, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1517\/17460441.2015.1041496","article-title":"Privileged scaffolds in lead generation","volume":"10","author":"Zhao","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cbpa.2010.02.018","article-title":"Privileged scaffolds for library design and drug discovery","volume":"14","author":"Welsch","year":"2010","journal-title":"Curr. Opin. Chem. Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2174\/1386207043328544","article-title":"Privileged Structures: Applications in Drug Discovery","volume":"7","author":"DeSimone","year":"2004","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"14629","DOI":"10.1021\/ja508343a","article-title":"Privileged Structures: Efficient Chemical \u201cNavigators\u201d toward Unexplored Biologically Relevant Chemical Spaces","volume":"136","author":"Kim","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2174\/0929867329666220705140846","article-title":"Benzoxazine: A Privileged Scaffold in Medicinal Chemistry","volume":"30","author":"Tang","year":"2023","journal-title":"Curr. Med. Chem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.2174\/1568026623666230330084058","article-title":"Coumarin as a Privileged and Medicinally Important Scaffold in the Treatment of Tuberculosis","volume":"23","author":"Gupta","year":"2023","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Skore\u0144ski, M., and Sie\u0144czyk, M. (2021). The Fellowship of Privileged Scaffolds\u2014One Structure to Inhibit Them All. Pharmaceuticals, 14.","DOI":"10.3390\/ph14111164"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.2174\/092986712800167356","article-title":"Privileged Structures-Dream or Reality: Preferential Organization of Azanaphthalene Scaffold","volume":"19","author":"Polanski","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"202","DOI":"10.32362\/2410-6593-2024-19-3-202-213","article-title":"L-Ornithine derivatives with structural hetaryl and alkyl moiety: Synthesis and antibacterial activity","volume":"19","author":"Bodrova","year":"2024","journal-title":"Fine Chem. Technol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e2300529","DOI":"10.1002\/ardp.202300529","article-title":"Design and synthesis of benzo[b]thiophene-based hybrids as novel antitubercular agents against MDR\/XDR Mycobacterium tuberculosis","volume":"357","author":"Rashad","year":"2024","journal-title":"Arch. Pharm."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Murnane, R., Zloh, M., Tanna, S., Allen, R., Santana-Gomez, F., Parish, T., and Brucoli, F. (2023). Synthesis and antitubercular activity of novel 4-arylalkyl substituted thio-, oxy- and sulfoxy-quinoline analogues targeting the cytochrome bc1 complex. Bioorg. Chem., 138.","DOI":"10.1016\/j.bioorg.2023.106659"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Irfan, A., Faisal, S., Zahoor, A.F., Noreen, R., Al-Hussain, S.A., Tuzun, B., Javaid, R., Elhenawy, A.A., Zaki, M.E.A., and Ahmad, S. (2023). In Silico Development of Novel Benzofuran-1,3,4-Oxadiazoles as Lead Inhibitors of M. tuberculosis Polyketide Synthase 13. Pharmaceuticals, 16.","DOI":"10.3390\/ph16060829"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/j.drudis.2020.07.017","article-title":"Fsp(3): A new parameter for drug-likeness","volume":"25","author":"Wei","year":"2020","journal-title":"Drug Discov. Today"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1021\/acs.jmedchem.0c01473","article-title":"Spirocyclic Scaffolds in Medicinal Chemistry","volume":"64","author":"Hiesinger","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1016\/j.bmcl.2014.06.081","article-title":"The use of spirocyclic scaffolds in drug discovery","volume":"24","author":"Zheng","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1080\/17460441.2016.1195367","article-title":"The utilization of spirocyclic scaffolds in novel drug discovery","volume":"11","author":"Zheng","year":"2016","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990\u20132021: A systematic analysis with forecasts to 2050","volume":"404","author":"Collaborators","year":"2024","journal-title":"Lancet"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/jac\/33.suppl_A.23","article-title":"Nitrofurantoin: Mechanism of action and implications for resistance development in common uropathogens","volume":"33","author":"McOsker","year":"1994","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Ryan, A., Kaplan, E., Laurieri, N., Lowe, E., and Sim, E. (2011). Activation of nitrofurazone by azoreductases: Multiple activities in one enzyme. Sci. Rep., 1.","DOI":"10.1038\/srep00063"},{"key":"ref_20","unstructured":"(2024, November 20). PDB Entry 6YJF. Available online: https:\/\/www.wwpdb.org\/pdb?id=pdb_00006yjf."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1128\/AAC.01407-05","article-title":"In vitro and in vivo antibacterial activities of DW-224a, a new fluoronaphthyridone","volume":"50","author":"Park","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ijantimicag.2010.02.022","article-title":"DNA gyrase and topoisomerase IV are dual targets of zabofloxacin in Streptococcus pneumoniae","volume":"36","author":"Park","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1021\/acsmedchemlett.7b00418","article-title":"Discovery of 3,3\u2019-Spiro[Azetidine]-2-oxo-indoline Derivatives as Fusion Inhibitors for Treatment of RSV Infection","volume":"9","author":"Shi","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"10986","DOI":"10.1021\/acs.jmedchem.4c00514","article-title":"Spiro-Azetidine Oxindoles as Long-Acting Injectables for Pre-Exposure Prophylaxis against Respiratory Syncytial Virus Infections","volume":"67","author":"Kesteleyn","year":"2024","journal-title":"J. Med. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1021\/acs.jmedchem.1c00034","article-title":"Identification and Profiling of a Novel Diazaspiro[3.4]octane Chemical Series Active against Multiple Stages of the Human Malaria Parasite Plasmodium falciparum and Optimization Efforts","volume":"64","author":"Dam","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1021\/acs.jmedchem.1c01993","article-title":"Drug Repurposing of Quisinostat to Discover Novel Plasmodium falciparum HDAC1 Inhibitors with Enhanced Triple-Stage Antimalarial Activity and Improved Safety","volume":"65","author":"Wang","year":"2022","journal-title":"J. Med. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"8822","DOI":"10.1021\/acs.jmedchem.3c00405","article-title":"Discovery of ARD-2051 as a Potent and Orally Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer","volume":"66","author":"Han","year":"2023","journal-title":"J. Med. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"13280","DOI":"10.1021\/acs.jmedchem.3c01264","article-title":"Discovery of ARD-1676 as a Highly Potent and Orally Efficacious AR PROTAC Degrader with a Broad Activity against AR Mutants for the Treatment of AR + Human Prostate Cancer","volume":"66","author":"Xiang","year":"2023","journal-title":"J. Med. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"115178","DOI":"10.1016\/j.ejmech.2023.115178","article-title":"2,6-diazaspiro[3.4]octan-7-one derivatives as potent sigma-1 receptor antagonists that enhanced the antinociceptive effect of morphine and rescued morphine tolerance","volume":"249","author":"Fu","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.bmcl.2016.01.064","article-title":"Discovery of spirocyclic proline tryptophan hydroxylase-1 inhibitors","volume":"26","author":"Goldberg","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Lukin, A., Komarova, K., Vinogradova, L., Dogonadze, M., Vinogradova, T., Yablonsky, P., Kazantsev, A., and Krasavin, M. (2023). Periphery Exploration around 2,6-Diazaspiro[3.4]octane Core Identifies a Potent Nitrofuran Antitubercular Lead. Molecules, 28.","DOI":"10.3390\/molecules28062529"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.mencom.2024.04.016","article-title":"Scaffold hopping in the oxadiazole antibiotic structure leads to more active compounds","volume":"34","author":"Vinogradova","year":"2024","journal-title":"Mendeleev Commun."},{"key":"ref_33","unstructured":"Lukin, A.Y., Vinogradova, T.I., Dogonadze, M.Z., Komarova, K.Y., Vinogradova, L.V., Dar\u2019in, D.V., Lavrova, A.I., Postnikov, E.B., Sychev, A.V., and Yablonskii, P.K. (2024, December 28). Compound of 8-(4-methyl-4h-1,2,4-triazol-3-yl)-6-(methylsulphonyl)-2-(5-nitro-2-furoyl)-2,6-diazaspiro[3.4]octane, having anti-tuberculosis activity against multidrug-resistant tuberculosis agent, and method for production thereof. RU2825646. Available online: https:\/\/patenton.ru\/patent\/RU2825646C1\/en."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Lukin, A., Komarova, K., Vinogradova, L., Rogacheva, E., Kraeva, L., and Krasavin, M. (2023). Synthesis and Antibacterial Evaluation of Ciprofloxacin Congeners with Spirocyclic Amine Periphery. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24020954"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1128\/AAC.46.8.2720-2722.2002","article-title":"Resazurin microtiter assay plate: Simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis","volume":"46","author":"Palomino","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejmech.2019.01.050","article-title":"Attachment of a 5-nitrofuroyl moiety to spirocyclic piperidines produces non-toxic nitrofurans that are efficacious in vitro against multidrug-resistant Mycobacterium tuberculosis","volume":"166","author":"Krasavin","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nprot.2007.521","article-title":"Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances","volume":"3","author":"Wiegand","year":"2008","journal-title":"Nat. Protoc."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.str.2011.11.001","article-title":"Structure of Ddn, the deazaflavin-dependent nitroreductase from Mycobacterium tuberculosis involved in bioreductive activation of PA-824","volume":"20","author":"Cellitti","year":"2012","journal-title":"Structure"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1107\/S0907444913015126","article-title":"Structure of arylamine N-acetyltransferase from Mycobacterium tuberculosis determined by cross-seeding with the homologous protein from M. marinum: Triumph over adversity","volume":"69","author":"Abuhammad","year":"2013","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"ref_40","unstructured":"(2024, November 21). PDB Entry 5NZ0. Available online: https:\/\/www.wwpdb.org\/pdb?id=pdb_00005nz0."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1016\/j.bmcl.2011.07.059","article-title":"Structure-based design of new DHFR-based antibacterial agents: 7-aryl-2,4-diaminoquinazolines","volume":"21","author":"Li","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_43","unstructured":"(2024, December 28). Available online: https:\/\/www.schrodinger.com\/life-science\/download\/release-notes\/release-2022-4\/."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Sastry","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","article-title":"OPLS4: Improving Force Field Accuracy on Challenging Regimes of Chemical Space","volume":"17","author":"Lu","year":"2021","journal-title":"J. Chem. Theory Comput."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Suenaga, A., Okimoto, N., Hirano, Y., and Fukui, K. (2012). An efficient computational method for calculating ligand binding affinities. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0042846"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/1\/207\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:56:10Z","timestamp":1760115370000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/1\/207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,29]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["ijms26010207"],"URL":"https:\/\/doi.org\/10.3390\/ijms26010207","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,29]]}}}